Bonaduce D, Spirito G, Petretta M, Romano E, Postiglione M, Ferrara N, Rengo F
G Ital Cardiol. 1979;9(12):1452-5.
In the present study we assessed plasma renin activity (PRA) variations induced by Ca++ antagonist antihypertensive drug Nifedipine in 8 normoreninaemic or hyporeninaemic hypertensive patients. On two successive days three venous blood samples were sampled, two in clinostatic position and the last one 120 min later in orthostatic position; on the second day 20 mg of nifedipine were administered sublingually. Nifedipine increases significantly PRA after orthostatic position compared with starting conditions (p < 0.01) and compared with the values recorded without the drug at the same times (p < 0.01). Both systolic and diastolic blood pressure decreased 15 and 120 min after nifedipine administration while heart rate increased at the same times. Acute nifedipine administration augments PRA in hypertensive subjects; explanatory hypoteses are proposed.
在本研究中,我们评估了钙拮抗剂降压药硝苯地平对8例正常肾素或低肾素高血压患者血浆肾素活性(PRA)的影响。连续两天采集三份静脉血样本,两份在卧位时采集,最后一份在120分钟后立位时采集;第二天舌下含服20mg硝苯地平。与起始状态相比,立位后硝苯地平使PRA显著升高(p<0.01),与同期未用药时记录的值相比也显著升高(p<0.01)。硝苯地平给药后15分钟和120分钟收缩压和舒张压均下降,同时心率升高。急性给予硝苯地平可增强高血压患者的PRA;并提出了解释性假说。